GO:0070682 proteasome regulatory particle assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070682 (proteasome regulatory particle assembly) describes the aggregation, arrangement and bonding together of a mature, active proteasome regulatory particle complex.
• The proteasome regulatory particle (RP, also called the 19S or PA700 particle) is built from a base subcomplex of six AAA+ ATPases (PSMC1-PSMC6) and a lid subcomplex of non-ATPase subunits (PSMD1-PSMD14).
• Assembly is not spontaneous; it is chaperone-driven and ordered, with dedicated assembly chaperones such as PAAF1, PSMD9, PSMD10, and the p97/VCP-associated factor UFD1L/NPL4 pathway participating in RP biogenesis.
• The RP docks onto the 20S core particle (CP) to form the 26S proteasome, the principal machine for ATP-dependent degradation of ubiquitinated proteins.
• Defects in RP assembly are linked to cancer, neurodegeneration, and developmental disorders, making the pathway a target for experimental modeling.
• CRISPR knockout, point-mutation, knock-in, and overexpression cell models, combined with CRISPR library screening and bioinformatics, are powerful tools to dissect RP assembly gene function.
Description
The proteasome regulatory particle (RP) is the ATP-driven subcomplex of the 26S proteasome that recognizes, unfolds, and translocates ubiquitinated substrates into the 20S core particle (CP) for degradation. The biological process GO:0070682, proteasome regulatory particle assembly, refers to the aggregation, arrangement and bonding together of a mature, active proteasome regulatory particle complex. This process is essential for maintaining protein homeostasis and for regulating virtually every cellular pathway that depends on controlled proteolysis. Understanding how the RP is assembled has become a central question in cell biology because misassembly or impaired assembly of the RP leads to proteotoxic stress and has been implicated in cancer and neurodegeneration. Unlike the core particle, which can assemble with the help of dedicated chaperones such as PAC1-PAC4 and POMP, the regulatory particle is built through an ordered, chaperone-assisted pathway that involves transient assembly intermediates and quality-control checkpoints. The first draft of the RP assembly manual emerged from genetic and biochemical studies in yeast and mammalian cells, revealing that the base and lid subcomplexes are preassembled separately before joining. More recent structural and interactomic studies have identified dynamic interactors and assembly checkpoints that ensure only properly formed RP intermediates proceed to the mature 26S proteasome. For researchers, GO:0070682 provides a precise ontological handle for annotating genes, designing perturbation experiments, and interpreting proteomics or imaging data focused on RP biogenesis. Because the RP is composed of at least 19 canonical subunits plus multiple assembly chaperones, dissecting its assembly requires systematic genetic and biochemical approaches. This article reviews the mechanism, key genes, disease links, and research methods relevant to proteasome regulatory particle assembly, with a focus on how CRISPR-based models can accelerate discovery.
proteasome regulatory particle assembly At A Glance
| GO ID | GO:0070682 |
|---|---|
| GO term | proteasome regulatory particle assembly |
| Ontology | biological_process |
| Synonym | proteasome regulatory complex assembly |
| Major function | Assembly of the mature, active proteasome regulatory particle (19S/PA700) that caps the 20S core particle to form the 26S proteasome |
| Subunits involved | Six AAA+ ATPases (PSMC1-PSMC6) in the base and up to 14 non-ATPase subunits (PSMD1-PSMD14) in the lid |
| Assembly chaperones | PAAF1, PSMD9, PSMD10, and other transient interactors that assist RP biogenesis |
| Cellular context | Cytoplasm and nucleus; assembly intermediates are dynamic and can be detected by interactomics and cryo-EM |
| Related process | Proteasome core particle assembly (GO:0070682 is specific to the regulatory particle) |
What Is GO:0070682?
GO:0070682, proteasome regulatory particle assembly, is the biological process in which the individual protein subunits of the proteasome regulatory particle are brought together, arranged, and bonded into a mature, active complex. This definition encompasses the ordered addition of base and lid subunits, the action of dedicated assembly chaperones, and the quality-control steps that ensure a functional RP is produced. The term is a child of proteasome assembly (GO:0070682 is a specific subprocess) and is distinct from core particle assembly, which involves a different set of chaperones and intermediates.
Why Is proteasome regulatory particle assembly Important in Cell Biology?
Proteasome regulatory particle assembly is important because the RP is the substrate-recognition and translocation module of the 26S proteasome, and without a properly assembled RP, cells cannot degrade ubiquitinated proteins efficiently. This process is therefore central to protein quality control, cell-cycle progression, signal transduction, and stress responses. Defects in RP assembly can cause proteotoxic stress and have been linked to cancer, neurodegeneration, and developmental disorders, making the pathway a focus for both basic and translational research. In addition, because RP assembly is chaperone-driven and highly regulated, it provides a paradigm for understanding how large multi-subunit complexes are built and quality-controlled in cells.
• Maintains protein homeostasis by ensuring a functional 26S proteasome for degradation of ubiquitinated proteins.
• Controls the half-life of key regulatory proteins involved in cell cycle, apoptosis, and signaling.
• Its dysfunction is implicated in cancer, where proteasome inhibitors are used therapeutically.
• Impaired RP assembly contributes to neurodegeneration through accumulation of toxic protein aggregates.
• Provides a model for chaperone-assisted assembly of large multi-subunit complexes.
• Assembly checkpoints ensure quality control and prevent premature or aberrant RP formation.
• Dynamic interactors at native proteasomes can be captured by advanced proteomics and cryo-EM.
• RP assembly genes are potential targets for CRISPR screening to identify modifiers of proteostasis.
• Understanding RP assembly may inform development of next-generation proteasome-targeting drugs.
• The process is conserved from yeast to humans, enabling cross-species experimental modeling.
What Happens During proteasome regulatory particle assembly?
Base subcomplex formation
In simple terms: The base is the motor of the regulatory particle, and it is built first from six ATPase subunits.
The base subcomplex of the proteasome regulatory particle contains six AAA+ ATPases, PSMC1 through PSMC6 (Rpt1-Rpt6 in yeast), which form a hexameric ring that docks onto the 20S core particle. Assembly of the base is assisted by dedicated chaperones, including PAAF1 (also known as Rpn14 in yeast) and other transient interactors, which prevent premature or incorrect association of the ATPases. The base also contains non-ATPase subunits such as PSMD1, PSMD2, PSMD3, and PSMD4, which contribute to substrate recognition and structural stability. Recent studies have shown that the assembly of the base is coordinated with the lid and that checkpoints monitor the proper interface between the base and the core particle.
Lid subcomplex formation
In simple terms: The lid is the part that recognizes ubiquitin tags and is assembled from non-ATPase subunits.
The lid subcomplex is composed of up to 14 non-ATPase subunits, including PSMD1-PSMD14, and is responsible for recognizing ubiquitinated substrates and deubiquitination. Lid assembly involves chaperones such as PSMD9 (Rpn4 in yeast) and PSMD10 (Nas6 in yeast), which assist in the ordered addition of lid subunits. The lid is preassembled separately from the base before joining to form the complete regulatory particle. Structural studies have revealed that the lid undergoes conformational changes during assembly and that its interaction with the base is critical for RP function.
Joining of base and lid
In simple terms: Once the base and lid are made, they come together to form the complete regulatory particle.
After the base and lid subcomplexes are preassembled, they join to form the mature regulatory particle in a process that requires additional chaperone activity and quality-control checkpoints. The assembly checkpoint of the RP is activated by coordinated actions of proteasomal ATPase chaperones, ensuring that only properly formed base-lid complexes proceed. The assembly chaperone Nas6 (PSMD10) selectively destabilizes 26S proteasomes with defective regulatory particle-core particle interfaces, acting as a quality-control factor. Dynamic interactors at native proteasomes have been captured by PhIX-MS and cryo-electron microscopy, revealing transient assembly intermediates.
Docking onto the 20S core particle
In simple terms: The finished regulatory particle attaches to the core particle to create the 26S proteasome.
The mature regulatory particle docks onto the 20S core particle to form the 26S proteasome, the principal machine for ATP-dependent degradation of ubiquitinated proteins. This docking step is mediated by interactions between the base ATPases and the alpha-ring of the core particle, and it is regulated by assembly chaperones and checkpoints. The assembly of the 26S proteasome is a dynamic process, and recent structural studies have visualized the conformational changes that occur during RP-CP association. Defects in this docking step can lead to accumulation of ubiquitinated proteins and proteotoxic stress.
Quality control and maturation
In simple terms: The cell checks that the regulatory particle is built correctly before it is used.
Quality-control mechanisms ensure that only correctly assembled regulatory particles are allowed to form 26S proteasomes. The assembly chaperone Nas6 (PSMD10) selectively destabilizes 26S proteasomes with defective RP-CP interfaces, preventing premature or aberrant complexes from accumulating. Proteasomal ATPase chaperones coordinate the assembly checkpoint, and their actions are required for the maturation of the RP. Dynamic interactors and assembly intermediates can be detected by advanced proteomic and structural methods, providing insights into the quality-control steps.
Key Genes Involved in GO:0070682 proteasome regulatory particle assembly
The following genes encode core subunits and assembly chaperones of the proteasome regulatory particle, and they are frequently studied in the context of GO:0070682.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PSMC1 | AAA+ ATPase subunit of the base; unfolds and translocates substrates | Knockout causes proteasome dysfunction; target for assembly studies |
| PSMC2 | AAA+ ATPase subunit of the base | Essential for RP assembly and function; studied in yeast and human cells |
| PSMC3 | AAA+ ATPase subunit of the base | Mutations affect substrate translocation; model for point-mutation studies |
| PSMC4 | AAA+ ATPase subunit of the base | Involved in RP assembly checkpoint; interacts with chaperones |
| PSMC5 | AAA+ ATPase subunit of the base | Regulated by assembly chaperones; target for knockout models |
| PSMC6 | AAA+ ATPase subunit of the base | Required for 26S proteasome formation; studied in cancer models |
| PSMD1 | Non-ATPase subunit of the base; substrate recognition | Knockout affects RP stability; used in interactome studies |
| PSMD2 | Non-ATPase subunit of the base | Essential for RP-CP docking; target for structural studies |
| PSMD3 | Non-ATPase subunit of the base | Involved in substrate recruitment; model for knock-in tagging |
| PSMD4 | Ubiquitin receptor subunit of the base | Binds ubiquitin chains; studied in neurodegeneration models |
| PSMD9 | Lid assembly chaperone | Assists lid formation; knockout leads to RP assembly defects |
| PSMD10 | Lid assembly chaperone (Nas6) | Quality-control factor; destabilizes defective 26S proteasomes |
| PSMD14 | Lid deubiquitinase subunit | Removes ubiquitin from substrates; target for point-mutation studies |
| PAAF1 | Base assembly chaperone | Assists ATPase ring formation; knockout impairs RP assembly |
| UFD1L | p97/VCP-associated factor | Participates in RP assembly quality control |
| NPL4 | p97/VCP-associated factor | Involved in processing of assembly intermediates |
| POMP | Core particle assembly chaperone | Indirectly affects RP assembly by coordinating CP formation |
| PAC1 | Core particle assembly chaperone | Coordinates CP assembly with RP availability |
How Is proteasome regulatory particle assembly Regulated?
Proteasome regulatory particle assembly is regulated at multiple levels, including the availability of assembly chaperones, the activity of proteasomal ATPase chaperones, and quality-control checkpoints. The assembly checkpoint of the RP is activated by coordinated actions of proteasomal ATPase chaperones, which ensure that only properly formed intermediates proceed. The chaperone Nas6 (PSMD10) selectively destabilizes 26S proteasomes with defective RP-CP interfaces, acting as a negative regulator of premature or aberrant assembly. In addition, the p97/VCP-associated factors UFD1L and NPL4 participate in the processing of assembly intermediates and quality control. Transcriptional and post-translational regulation of RP subunit genes can also influence assembly efficiency, although the precise mechanisms are still being elucidated.
proteasome regulatory particle assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PSMC1 | Cancer, neurodegeneration | Knockout cell lines and mouse models |
| PSMD10 | Cancer, quality control defects | Point-mutation knock-in to disrupt chaperone function |
| PSMD9 | Developmental disorders | Knockout and overexpression models |
| PAAF1 | Proteostasis imbalance | CRISPR knockout in human cell lines |
| UFD1L | Neurodegeneration | Knock-in of tagged alleles for interactomics |
Cancer
Dysregulation of proteasome regulatory particle assembly can contribute to cancer by altering the degradation of oncoproteins and tumor suppressors. Proteasome inhibitors such as bortezomib target the 20S core particle, but emerging evidence suggests that RP assembly factors may also be relevant to drug resistance and cancer cell survival. Mutations or altered expression of RP subunits and assembly chaperones have been observed in various cancers, making them potential biomarkers or therapeutic targets.
Neurodegeneration
Impaired proteasome function, including defects in RP assembly, is linked to neurodegenerative diseases such as Alzheimer's and Parkinson's, where accumulation of ubiquitinated protein aggregates is a hallmark. The RP is essential for clearing toxic proteins, and its dysfunction can exacerbate neuronal stress and death. Experimental models with mutations in RP assembly genes are used to study the contribution of proteostasis failure to neurodegeneration.
Developmental disorders
Because the proteasome is essential for cell cycle progression and differentiation, defects in RP assembly can cause developmental disorders. Mutations in proteasome subunit genes have been identified in patients with developmental delay and other congenital anomalies, although the specific role of RP assembly chaperones in these conditions is still being investigated. Model organisms and patient-derived cells are used to study these rare disorders.
From proteasome regulatory particle assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of complete loss of an RP subunit? | CRISPR knockout cell line |
| How does a specific point mutation affect RP assembly? | Point-mutation knock-in via CRISPR |
| Where and when is an RP subunit expressed? | Tagged knock-in (e.g., GFP or HA) |
| What happens when an assembly chaperone is overexpressed? | Overexpression cell model |
| Which genes modify RP assembly defects? | CRISPR library screening |
| How do assembly intermediates change dynamically? | Proteomics and cryo-EM with tagged alleles |
How to Study the proteasome regulatory particle assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| PhIX-MS | Dynamic interactors at native proteasomes | Identifying assembly intermediates and chaperones |
| Cryo-EM | High-resolution structures of proteasome complexes | Visualizing RP assembly states |
| CRISPR knockout | Loss-of-function phenotypes | Determining essentiality of RP subunits |
| CRISPR library screening | Genome-wide modifiers of RP assembly | Identifying synthetic lethal genes |
| Native gel electrophoresis | Assembly intermediates and mature 26S | Monitoring assembly defects |
| Sucrose gradient centrifugation | Sedimentation profiles of proteasome complexes | Separating RP subcomplexes |
| Immunoblotting | Subunit incorporation and stability | Validating knockout or knock-in models |
| Activity assays | Peptidase and ATPase activity | Measuring functional maturation of RP |
Proteomics and interactomics
Mass spectrometry-based proteomics, including PhIX-MS, can identify dynamic interactors and assembly intermediates of the proteasome regulatory particle. These methods allow researchers to capture transient chaperone-subunit interactions and to quantify changes in RP composition under different conditions. Affinity purification of tagged RP subunits followed by mass spectrometry is a standard approach to map the assembly interactome.
Structural biology
Cryo-electron microscopy (cryo-EM) has been used to determine the structures of native proteasomes and their dynamic interactors, providing near-atomic resolution views of RP assembly intermediates. Structural studies reveal conformational changes that occur during base and lid formation and during docking onto the 20S core particle. These methods are essential for understanding the molecular details of assembly checkpoints and quality control.
Genetic screens and CRISPR
CRISPR knockout and CRISPR library screening are powerful tools to identify genes required for proteasome regulatory particle assembly. Genome-wide screens can uncover modifiers of RP assembly defects and reveal synthetic lethal interactions. Point-mutation knock-in models allow precise dissection of chaperone functions and assembly checkpoints.
Biochemical assays
Native gel electrophoresis, sucrose gradient centrifugation, and activity assays can separate and quantify proteasome assembly intermediates and mature 26S proteasomes. These biochemical methods are often combined with genetic perturbations to determine the step at which assembly is blocked. Immunoblotting with subunit-specific antibodies can monitor the incorporation of individual subunits into the RP.
How CRISPR Can Be Used to Study GO:0070682 proteasome regulatory particle assembly
Knockout
CRISPR knockout of RP subunit genes or assembly chaperones (e.g., PSMC1, PSMD10, PAAF1) can reveal their essentiality for proteasome regulatory particle assembly and cell viability. Knockout cell lines are used to determine whether a gene is required for base or lid formation and to identify compensatory mechanisms. These models are also valuable for testing drug sensitivity and for studying disease-associated phenotypes.
Point Mutation
Point-mutation knock-in via CRISPR allows researchers to introduce specific amino acid changes that disrupt chaperone activity or subunit interfaces without completely eliminating the protein. Such models are useful for dissecting the precise roles of assembly checkpoints and quality-control factors, such as the Nas6 (PSMD10) destabilization of defective 26S proteasomes. Point mutations can also mimic patient-derived variants to study disease mechanisms.
Knock-in
Tagged knock-in (e.g., GFP, HA, or BirA) of RP subunits enables live-cell imaging, affinity purification, and interactome studies. Knock-in of reporter cassettes can be used to monitor assembly kinetics and to isolate specific assembly intermediates. These models are particularly valuable for cryo-EM and proteomics workflows that require native expression levels.
Overexpression
Overexpression of assembly chaperones or RP subunits can drive the formation of assembly intermediates or mature proteasomes, allowing researchers to study the consequences of excess subunits. Overexpression models are useful for identifying dominant-negative effects and for testing whether a chaperone is limiting for assembly. They can also be combined with knockout backgrounds to rescue or exacerbate phenotypes.
How EDITGENE Supports proteasome regulatory particle assembly Research
Researchers studying proteasome regulatory particle assembly-related genes often need to determine whether a candidate gene is causally involved in RP biogenesis or whether its perturbation affects proteostasis more broadly. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional dissection of GO:0070682 and its associated genes.
Contact EDITGENE today to design your custom CRISPR model for proteasome regulatory particle assembly research.
Frequently Asked Questions About proteasome regulatory particle assembly
What is GO:0070682?
GO:0070682 is the Gene Ontology term for proteasome regulatory particle assembly, the biological process of building the mature, active regulatory particle of the 26S proteasome.
What genes are involved in proteasome regulatory particle assembly?
Key genes include the AAA+ ATPases PSMC1-PSMC6, non-ATPase subunits PSMD1-PSMD14, and assembly chaperones such as PAAF1, PSMD9, and PSMD10.
What is the proteasome regulatory particle?
The regulatory particle (also called 19S or PA700) is the subcomplex of the 26S proteasome that recognizes, unfolds, and translocates ubiquitinated substrates into the 20S core particle.
How is the proteasome regulatory particle assembled?
It is assembled through an ordered, chaperone-assisted pathway in which the base and lid subcomplexes form separately and then join before docking onto the 20S core particle.
What chaperones assist proteasome regulatory particle assembly?
Chaperones such as PAAF1, PSMD9, PSMD10 (Nas6), and p97/VCP-associated factors UFD1L and NPL4 assist RP assembly and quality control.
Why is proteasome regulatory particle assembly important for disease?
Defects in RP assembly can cause proteotoxic stress and are linked to cancer, neurodegeneration, and developmental disorders.
What methods are used to study proteasome regulatory particle assembly?
Common methods include CRISPR knockout, point-mutation knock-in, tagged knock-in, proteomics (PhIX-MS), cryo-EM, native gel electrophoresis, and activity assays.
Can CRISPR be used to study proteasome regulatory particle assembly?
Yes, CRISPR knockout, point-mutation, knock-in, and overexpression models are widely used to dissect RP assembly gene function and checkpoints.
What is the assembly checkpoint of the proteasome regulatory particle?
The assembly checkpoint is a quality-control mechanism activated by proteasomal ATPase chaperones that ensures only properly formed RP intermediates proceed to mature 26S proteasomes.
How does EDITGENE support proteasome regulatory particle assembly research?
EDITGENE provides CRISPR knockout, point-mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services for RP assembly genes.
Conclusion
Proteasome regulatory particle assembly (GO:0070682) is a fundamental biological process that builds the substrate-recognition module of the 26S proteasome. It is chaperone-driven, ordered, and subject to quality-control checkpoints that ensure only functional complexes are produced. Dysregulation of this process is linked to cancer, neurodegeneration, and developmental disorders, making it a compelling area for both basic and translational research. Advances in CRISPR-based models, proteomics, and structural biology are rapidly expanding our understanding of RP assembly and its role in health and disease.
References
- 1. Gu ZC et al.. 2014. Proteasome assembly.. Cell Mol Life Sci 71(24):4729-45 PMID: 25107634
- 2. Park S et al.. 2010. Assembly manual for the proteasome regulatory particle: the first draft.. Biochem Soc Trans 38(Pt 1):6-13 PMID: 20074027
- 3. Rosenzweig R et al.. 2008. Chaperone-driven proteasome assembly.. Biochem Soc Trans 36(Pt 5):807-12 PMID: 18793141
- 4. Nahar A et al.. 2022. Assembly checkpoint of the proteasome regulatory particle is activated by coordinated actions of proteasomal ATPase chaperones.. Cell Rep 39(10):110918 PMID: 35675778
- 5. Lee K et al.. 2026. Structures of dynamic interactors at native proteasomes by PhIX-MS and cryo-electron microscopy.. Mol Cell 86(15):3067-3085.e13 PMID: 42476128
- 6. Warnock JL et al.. 2023. Assembly chaperone Nas6 selectively destabilizes 26S proteasomes with defective regulatory particle-core particle interfaces.. J Biol Chem 299(2):102894 PMID: 36634850
- 7. Budenholzer L et al.. 2017. Proteasome Structure and Assembly.. J Mol Biol 429(22):3500-3524 PMID: 28583440
- 8. Schnell HM et al.. 2022. Chaperone-mediated assembly of the proteasome core particle - recent developments and structural insights.. J Cell Sci 135(8) PMID: 35451017
